Capricor Therapeutics, Inc. (CAPR)
8.95
+0.01
(+0.11%)
USD |
NASDAQ |
Oct 02, 16:00
9.02
+0.07
(+0.78%)
After-Hours: 20:00
Capricor Therapeutics Max Drawdown (5Y) : 91.80% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 91.80% |
| August 31, 2026 | 91.80% |
| July 31, 2026 | 91.80% |
| June 30, 2026 | 91.80% |
| May 31, 2026 | 91.87% |
| April 30, 2026 | 93.35% |
| March 31, 2026 | 93.35% |
| February 28, 2026 | 93.35% |
| January 31, 2026 | 93.35% |
| December 31, 2025 | 93.35% |
| November 30, 2025 | 93.35% |
| October 31, 2025 | 93.35% |
| September 30, 2025 | 93.35% |
| August 31, 2025 | 93.35% |
| July 31, 2025 | 93.35% |
| June 30, 2025 | 93.35% |
| May 31, 2025 | 93.35% |
| April 30, 2025 | 93.35% |
| March 31, 2025 | 98.80% |
| February 28, 2025 | 99.08% |
| January 31, 2025 | 99.08% |
| December 31, 2024 | 99.08% |
| November 30, 2024 | 99.08% |
| October 31, 2024 | 99.08% |
| September 30, 2024 | 99.08% |
| Date | Value |
|---|---|
| August 31, 2024 | 99.08% |
| July 31, 2024 | 99.08% |
| June 30, 2024 | 99.08% |
| May 31, 2024 | 99.08% |
| April 30, 2024 | 99.08% |
| March 31, 2024 | 99.08% |
| February 29, 2024 | 99.08% |
| January 31, 2024 | 99.08% |
| December 31, 2023 | 99.08% |
| November 30, 2023 | 99.08% |
| October 31, 2023 | 99.08% |
| September 30, 2023 | 99.08% |
| August 31, 2023 | 99.08% |
| July 31, 2023 | 99.08% |
| June 30, 2023 | 99.08% |
| May 31, 2023 | 99.08% |
| April 30, 2023 | 99.08% |
| March 31, 2023 | 99.08% |
| February 28, 2023 | 99.08% |
| January 31, 2023 | 99.08% |
| December 31, 2022 | 99.08% |
| November 30, 2022 | 99.08% |
| October 31, 2022 | 99.08% |
| September 30, 2022 | 99.08% |
| August 31, 2022 | 99.08% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ARS Pharmaceuticals, Inc. | 95.20% |
| SELLAS Life Sciences Group, Inc. | 99.91% |
| Sionna Therapeutics, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 58.17% |
| Cytokinetics, Inc. | 72.39% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 8.821 |
| Beta (5Y) | 0.6084 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 238.0% |
| Historical Sharpe Ratio (5Y) | 0.0626 |
| Historical Sortino (5Y) | 0.2763 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.92% |